首页 | 本学科首页   官方微博 | 高级检索  
     

pGenesil-siHBV X 对 HepG2.2.15 细胞 HBV 表达和复制的抑制效果研究
引用本文:杨慧,赵中夫,张国英,张芸,刘明社,杨柳絮. pGenesil-siHBV X 对 HepG2.2.15 细胞 HBV 表达和复制的抑制效果研究[J]. 中国医药生物技术, 2007, 2(2): 114-117
作者姓名:杨慧  赵中夫  张国英  张芸  刘明社  杨柳絮
作者单位:1. 030001,太原,山西医科大学第一医院感染病科
2. 长治医学院肝病研究所
摘    要: 目的 研究针对HBV X基因区设计的小干扰RNA(siRNA)表达载体质粒pGenesil-siHBV X 对HepG2.2.15细胞HBV表达和复制的抑制效果及特异性。方法 针对HBV X区设计siRNA表达载体质粒pGenesil- siHBV X。分别用培养液(空白对照)、脂质体Metafectene、pGenesil 空载体、pGenesil-siHK(阴性对照)、pGenesil-siAFP(特异性对照)、pGenesil-siHBV X处理或转染HepG2.2.15细胞各3次。于每次转染后24 h,取各组细胞培养上清液,用时间分辨荧光免疫测定技术检测上清液中HBsAg和HBeAg含量,用化学发光法检测AFP含量,用PCR荧光定量技术检测HBV-DNA复制水平。结果 pGenesil-siHBV X转染能抑制HepG2.2.15细胞对HBV标志物的表达,且抑制作用随转染次数增加而增强。第3次转染后,pGenesil-siHBV X组细胞上清液中 HBsAg、 HBeAg和HBV-DNA检测结果分别为(6.26 ± 1.07)ng/ml 、(0.13 ± 0.05)Ncu/ml和(3.01 ± 0.40)×107拷贝/ml,与空白对照组的(22.50 ± 1.39)ng/ml、(1.12 ± 0.11)Ncu/ml和(12.33 ± 1.28)×107拷贝/ml比较,差异有统计学意义(t值分别为12.80、12.21、9.71,P < 0.05);pGenesil-siHBV X 转染不影响细胞对AFP的表达(t = 0.18,P = 0.86)。结论 pGenesil-siHBV X可以有效和特异地抑制HepG 2.2. 15细胞HBV-DNA的复制及HBsAg和HBeAg表达。

关 键 词:肝炎病毒,乙型  RNA 干扰  质粒  遗传载体  细胞系,肿瘤
收稿时间:2007-01-18
修稿时间:2007-01-18

Suppressing effect of pGenesil-siHBV X on the expression and replication of hepatitis B virus in HepG2.2.15 cells
YANG Hui,ZHAO Zhong-fu,ZHANG Guo-ying,ZHANG Yun,LIU Ming-she,YANG Liu-xu. Suppressing effect of pGenesil-siHBV X on the expression and replication of hepatitis B virus in HepG2.2.15 cells[J]. Chinese Medicinal Biotechnology, 2007, 2(2): 114-117
Authors:YANG Hui  ZHAO Zhong-fu  ZHANG Guo-ying  ZHANG Yun  LIU Ming-she  YANG Liu-xu
Abstract:Objective To evaluate the effect of pGenesil-siHBV X on the replication and expression of hepatitis B virus in HepG2.2.15 cells. Methods HepG2.2.15 cells were cultured in six-well plate and treated 1 to 3 times with the culture fluid (blank control group), METAFECTENE, pGenesil, PGenesil-HK (negative control group), PGenesil-siAFP (specific control group), and pGenesil-siHBV X. After been treated for 24 hours, the expression of HBV antigen in the supernatant of all the groups were determined with Time-resolved Immunofluorometric Assay kit (TRFIA), the level of AFP was detected by chemiluminescent method, and the level of HBV-DNA was examined by fluorescence quantitative PCR. Results pGenesil-siHBV X could effectively and specifically inhibit the levels of HBsAg, HBeAg, and HBV-DNA, and the inhibiting effects increased with the times of transfection. Compared to the blank control group, the levels of HBsAg, HBeAg, and HBV-DNA in the supernatant in the pGenesil-siHBV X group decreased obviously after 3 times of transfection [(22.50 ± 1.39) ng/ml, (1.12 ± 0.11) Ncu/ml, and (12.33 ± 1.28) × 107 copies/ml vs. (6.26 ± 1.07) ng/ml, (0.13 ± 0.05) Ncu/ml, and (3.01 ± 0.40) × 107 copies/ml; t = 12.80, 12.21 and 9.71; P < 0.05]. Furthermore, pGenesil-siHBV X did not suppress the expression of AFP gene (t = 0.18, P = 0.86). Conclusion pGenesil-siHBV X could effectively and specifically inhibit HBV replication and expression of HBsAg and HBeAg in HepG2.2.15 cells.
Keywords:Hepatitis B virus  RNA interference  Plasmids  Genetic vectors  Cell line   tumor
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《中国医药生物技术》浏览原始摘要信息
点击此处可从《中国医药生物技术》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号